secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oncotelic Therapeutics, Inc. (OTLC)
CIK:        0000908259
Form:       8-K
Filed at:   2026-07-14T20:00:33+00:00
Accession:  0001493152-26-033172
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oncotelic presents corporate presentation to employees; details not available in filing
--------------------------------------------------------------------------------

- Presentation given on July 13, 2026 to employees, directors, officers, and advisors.
- No specific financial or operational updates are disclosed in the filing text.
- Exhibit 99.1 (Corporate Presentation) was not provided in the appended text.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/908259/000149315226033172/0001493152-26-033172-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/908259/000149315226033172/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-033172

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer